UBS Group AG - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$87,166
-41.0%
20,271
-24.6%
0.00%
Q2 2023$147,615
+899.0%
26,888
+664.3%
0.00%
Q1 2023$14,776
+9.6%
3,518
-27.7%
0.00%
Q4 2022$13,479
+92.6%
4,866
+74.5%
0.00%
Q3 2022$7,000
+250.0%
2,789
+350.6%
0.00%
Q2 2022$2,000
-89.5%
619
-80.0%
0.00%
Q1 2022$19,000
-74.7%
3,101
-71.1%
0.00%
Q4 2021$75,000
+226.1%
10,715
+231.4%
0.00%
Q3 2021$23,000
+666.7%
3,233
+810.7%
0.00%
Q2 2021$3,000
-90.3%
355
-93.7%
0.00%
Q1 2021$31,000
-18.4%
5,633
-37.1%
0.00%
Q4 2020$38,000
+1166.7%
8,950
+748.3%
0.00%
Q3 2020$3,000
-92.3%
1,055
-91.5%
0.00%
Q2 2020$39,00012,440
+21724.6%
0.00%
Q1 2020$0
-100.0%
57
-98.1%
0.00%
Q4 2019$9,000
-18.2%
3,018
-15.9%
0.00%
Q3 2019$11,000
+22.2%
3,588
-23.1%
0.00%
Q2 2019$9,000
+125.0%
4,667
+366.7%
0.00%
Q1 2019$4,000
-91.5%
1,000
-93.2%
0.00%
Q4 2018$47,000
-44.7%
14,742
-8.0%
0.00%
Q3 2018$85,000
+136.1%
16,028
+143.4%
0.00%
Q2 2018$36,000
+800.0%
6,586
+778.1%
0.00%
Q1 2018$4,000
-33.3%
750
-58.8%
0.00%
Q4 2017$6,000
-14.3%
1,821
+0.5%
0.00%
Q3 2017$7,000
-22.2%
1,812
-50.6%
0.00%
Q2 2017$9,000
-18.2%
3,669
-12.9%
0.00%
Q1 2017$11,000
-21.4%
4,210
-11.6%
0.00%
Q4 2016$14,000
-26.3%
4,760
-32.2%
0.00%
Q3 2016$19,000
+58.3%
7,025
+70.7%
0.00%
Q2 2016$12,000
+100.0%
4,116
+122.5%
0.00%
Q1 2016$6,000
-72.7%
1,850
-70.7%
0.00%
Q4 2015$22,000
+214.3%
6,315
+260.9%
0.00%
Q3 2015$7,000
-30.0%
1,7500.0%0.00%
Q2 2015$10,000
-16.7%
1,750
-13.0%
0.00%
Q1 2015$12,000
+9.1%
2,011
+3.1%
0.00%
Q4 2014$11,0001,9500.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q4 2020
NameSharesValueWeighting ↓
AMH Equity Ltd 2,053,907$8,626,4099.88%
B. Riley Asset Management, LLC 3,408,796$14,316,9435.93%
Meros Investment Management, LP 1,124,206$4,721,6652.69%
Harvey Partners, LLC 2,712,700$11,393,3401.41%
Archon Capital Management LLC 1,361,769$5,719,4301.28%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,947,329$12,378,7820.80%
BARD ASSOCIATES INC 291,297$1,223,4480.50%
Portolan Capital Management 1,043,546$4,382,8930.42%
HEARTLAND ADVISORS INC 1,200,000$5,040,0000.31%
EAM Investors, LLC 345,546$1,451,2930.28%
View complete list of HARVARD BIOSCIENCE INC shareholders